On October 7, Tencent and Medopad, the British mobile medical company, joined hands with Professor Ray Chaudhuri, the first international clinical person in the field of Parkinson's disease, to hold a press conference in Hong Kong for the signing of a strategic cooperation contract and a memorandum of cooperation in scientific research. The three parties will cooperate deeply in the clinical and application fields of Parkinson's disease, jointly start the joint research and development of Parkinson's AI assistant diagnosis technology, and realize the application of AI assistant assessment technology of motor function based on Parkinson's disease clinical assessment standard in mobile and family scenes. The rapid intelligent movement function can be achieved by using smart phones. Assessment.
Dr. Fan Wei (left), Professor Ray Chaudhuri (middle), CEO and founder of Tencent Medical AI Laboratory, Dan Vahdat (right) jointly initiated Parkinson's AI Auxiliary International Co-development
Dr. Fan Wei, director of Tencent Medical AI Laboratory, said that in this collaboration, Tencent will provide AI technology and capabilities in video analysis of Parkinson's disease motor function, combined with the mobile medical application of Medopad. Work together to promote early diagnosis and early screening of Parkinson's disease and daily evaluation of the application scenarios
Professor Ray Chaudhuri, the world's leading Parkinson's expert, professor of dyskinesia and director of Parkinson's general diagnosis at King's College London, is pleased to be able to escort the development of Parkinson's AI co-diagnosis technology in this collaboration from a clinical perspective, he said:
The signing conference was held during the twenty-second International Conference on Parkinson and dyskinesia in 2018. At the same time, Parkinson's disease motor function intelligent assessment system exhibited and presented at the conference, arousing the attention of experts and scholars in the industry worldwide.
Tencent and Medopad jointly participate in the 22nd International Congress on Parkinson's Disease and Dysfunction, 2008
Tencent AI technology helps doctors speed up diagnosis 10 times, and Medopad joint international clinical trial.
Parkinson's disease (PD) is a typical chronic disease in the elderly. However, due to the inconspicuous early symptoms, it often appears that the treatment is not timely, the delayed diagnosis rate is high, and the treatment rate is low. Early detection of patients after treatment can alleviate symptoms, prevent and reduce long-term motor complications, and lead a normal life. Otherwise, patients may suffer from illness for a long time, and the quality of life is seriously reduced.
At present, the traditional diagnostic scale is used to diagnose Parkinson's disease in hospitals. Patients need to complete each part of the prescribed action under the guidance of the doctor, the doctor according to the completion of the patient's point by point, the whole process takes about 30 minutes or more. This method of diagnosis relies on verbal communication, the time cost is high, and the score mainly relies on the doctor's naked eye observation, such as the distance, amplitude, frequency, etc., lack of quantitative indicators, may lead to subjective bias.
To this end, Tencent Medical AI Laboratory, based on a collaboration with Professor Wang Jian of Department of Neurology, Huashan Hospital, has developed a AI model for evaluating Parkinson's disease through motion testing.
Together with Medopad and Professor Ray Chaudhuri, Tencent's international collaboration aims to integrate the above-mentioned AI technologies with the European Clinical Assessment Standards for Parkinson's Disease, connect to the Medopad platform and work with other data capture functions on the platform to enable clinical and home environment use, greatly reducing the assessment time and improving medical care. Health work efficiency, reduce the cost of treatment or rehabilitation.
Dr. Fan Wei introduced the motion video analysis technology used in the system, which has the ability of depth learning and image recognition. Hundreds of identifiable key nodes are set on the human body, and the detectors are used to track the changes of these nodes in frequency, distance, angle and speed, so as to build models to train AI.
Tencent and Medopad boost Parkinsonian access
The continuous upgrading of technology and Tencent's attitude of open cooperation are inextricably linked. For a long time, Tencent has defined itself as
Open cooperation also provides more possibilities for the spread of new technologies. In April this year, the General Office of the State Council officially issued a draft resolution on the promotion of
With the help of AI technology, Tencent Parkinson's disease motor function intelligent evaluation system can achieve Parkinson's disease motor function evaluation.
Medopad's smartphone platform, combined with Tencent's AI capabilities, will help patients conduct exercise evaluations outside the clinical environment and share results in real time, allowing doctors to assess patients' disease progress more effectively. This collaboration will promote medical services from
Medopad CEO and founder Dan Vahdat said:
This means that, in the future, disease can be assessed and managed in multiple scenarios by installing a mobile application that combines Tencent's Parkinson AI technology, such as the Medopad platform. Users can use their smartphones in their home and work environments. Health management should be carried out anytime and anywhere to assess the state of movement of themselves and their family members.